InsiderGauge
Checking updates…
Dashboard

Maier Paul Vinsider trades

In SEC Form 4 filings, Maier Paul V is listed as Director of International Stem Cell CORP (ISCO) and Director of Eton Pharmaceuticals, Inc. (ETON). In the last 90 days, Maier Paul V sold $2.96M across 2 companies on the open market and bought none.

Companies and roles

CompanyRoleTransactionsLast filed
ISCOInternational Stem Cell CORPDirector2Sep 17
ETONEton Pharmaceuticals, Inc.Director7Aug 31

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-08-31

Dashed line = amended filing (Form 4/A)

CompanyTradedFiledTypeSharesPriceValueOwned after10b5-1 planFiling
ISCOInternational Stem Cell CORPSep 16Sep 17D · derivative30,000$0.12$3,600not reportedNoForm 4
ISCOInternational Stem Cell CORPSep 11Sep 15S32,802$0.32Sale −$10,497not reportedNoForm 4
ETONEton Pharmaceuticals, Inc.Aug 28Aug 314/AM50,000$3.78$189,000109,745NoForm 4/A
ETONEton Pharmaceuticals, Inc.Aug 28Aug 314/AS36,387$58.64Sale −$2,133,73473,358NoForm 4/A
ETONEton Pharmaceuticals, Inc.Aug 28Aug 314/AS13,485$60.21Sale −$811,93259,873NoForm 4/A
ETONEton Pharmaceuticals, Inc.Aug 28Aug 314/AS128$61.77Sale −$7,90759,745NoForm 4/A
ETONEton Pharmaceuticals, Inc.Aug 28Aug 314/AM12,500$7.31$91,37572,245NoForm 4/A
ETONEton Pharmaceuticals, Inc.Aug 28Aug 314/AM · derivative50,000$3.78$189,000not reportedNoForm 4/A
ETONEton Pharmaceuticals, Inc.Aug 28Aug 314/AM · derivative12,500$7.31$91,375not reportedNoForm 4/A

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.